BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33678508)

  • 1. Adjuvant chemotherapy for pulmonary sarcomatoid carcinoma: A retrospective analysis of the National Cancer Database.
    Abdallah HM; Martinez-Meehan D; Lutfi W; Dhupar R; Grenda T; Schuchert MJ; Christie NA; Luketich JD; Okusanya OT
    J Thorac Cardiovasc Surg; 2022 May; 163(5):1669-1681.e3. PubMed ID: 33678508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary Sarcomatoid Carcinoma: Experience From SEER Database and Shanghai Pulmonary Hospital.
    Sun L; Dai J; Chen Y; Duan L; He W; Chen Q; Wang H; Zhu Y; Zhang H; Jiang G; Zhang P
    Ann Thorac Surg; 2020 Aug; 110(2):406-413. PubMed ID: 32268141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant chemotherapy is not a decisive factor in improving the overall survival of pulmonary sarcoma: A population-based study.
    Liang L; Liu Z; Wang C; Xie S
    Front Oncol; 2022; 12():940839. PubMed ID: 36091171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcomatoid Carcinoma of the Lung: The Mayo Clinic Experience in 127 Patients.
    Maneenil K; Xue Z; Liu M; Boland J; Wu F; Stoddard SM; Molina J; Yang P
    Clin Lung Cancer; 2018 May; 19(3):e323-e333. PubMed ID: 29454534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Delayed Adjuvant Chemotherapy With Survival After Lung Cancer Surgery.
    Salazar MC; Rosen JE; Wang Z; Arnold BN; Thomas DC; Herbst RS; Kim AW; Detterbeck FC; Blasberg JD; Boffa DJ
    JAMA Oncol; 2017 May; 3(5):610-619. PubMed ID: 28056112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy may improve prognosis after resection of stage I lung cancer with lymphovascular invasion.
    Wang S; Xu J; Wang R; Qian F; Yang W; Qiao R; Zhang B; Qian J; Yu K; Han B
    J Thorac Cardiovasc Surg; 2018 Nov; 156(5):2006-2015.e2. PubMed ID: 30104070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathologic Findings and Long-Term Results After Surgical Treatment for Pulmonary Sarcomatoid Tumors: A Multicenter Analysis.
    Lococo F; Rapicetta C; Cardillo G; Stefani A; Margaritora S; Leuzzi G; Rossi G; Petracca Ciavarella L; Morandi U; Facciolo F; Ricchetti T; Cesario A; Paci M
    Ann Thorac Surg; 2017 Apr; 103(4):1142-1150. PubMed ID: 28027731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary sarcomatoid carcinoma: an analysis of a rare cancer from the Surveillance, Epidemiology, and End Results database.
    Rahouma M; Kamel M; Narula N; Nasar A; Harrison S; Lee B; Stiles B; Altorki NK; Port JL
    Eur J Cardiothorac Surg; 2018 Apr; 53(4):828-834. PubMed ID: 29240878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit of adjuvant chemotherapy after resection of stage II (T1-2N1M0) non-small cell lung cancer in elderly patients.
    Berry MF; Coleman BK; Curtis LH; Worni M; D'Amico TA; Akushevich I
    Ann Surg Oncol; 2015 Feb; 22(2):642-8. PubMed ID: 25192680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy for advanced pulmonary sarcomatoid carcinoma: a population-based propensity score matching study.
    Wang F; Yu X; Han Y; Gong C; Yan D; Yang L; Li J; Liu S
    BMC Pulm Med; 2023 Jul; 23(1):262. PubMed ID: 37454075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemotherapy following stereotactic body radiotherapy for early stage non-small-cell lung cancer is associated with lower overall: A National Cancer Database Analysis.
    Foster CC; Rusthoven CG; Sher DJ; Feldman L; Pasquinelli M; Spiotto MT; Koshy M
    Lung Cancer; 2019 Apr; 130():162-168. PubMed ID: 30885339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of age on the efficacy of adjuvant chemotherapy for resected non-small cell lung cancer.
    Ganti AK; Williams CD; Gajra A; Kelley MJ
    Cancer; 2015 Aug; 121(15):2578-85. PubMed ID: 25873330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of adjuvant chemotherapy on survival of patients with stage IB non-small cell lung cancer with visceral pleural invasion.
    Xie J; Zhang X; Hu S; Peng WD; Xu B; Li Y; Zhang SJ; Li Q; Li C
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2231-2239. PubMed ID: 32533405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of a Competing Risk Nomogram in Patients with Pulmonary Sarcomatoid Carcinoma.
    Liang Z; Zhang E; Duan L; Weygant N; An G; Hu B; Yao J
    Technol Cancer Res Treat; 2022; 21():15330338211068960. PubMed ID: 35179409
    [No Abstract]   [Full Text] [Related]  

  • 15. Adjuvant chemotherapy for elderly patients with non-small-cell lung cancer.
    Yamanashi K; Okumura N; Yamamoto Y; Takahashi A; Nakashima T; Matsuoka T; Kameyama K
    Asian Cardiovasc Thorac Ann; 2017 Jun; 25(5):371-377. PubMed ID: 28592139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in stage I, II resectable non-small cell lung cancer: a retrospective multicohort study for outcome prediction.
    Vaidya P; Bera K; Gupta A; Wang X; Corredor G; Fu P; Beig N; Prasanna P; Patil PD; Velu PD; Rajiah P; Gilkeson R; Feldman MD; Choi H; Velcheti V; Madabhushi A
    Lancet Digit Health; 2020 Mar; 2(3):e116-e128. PubMed ID: 33334576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary Sarcomatoid Carcinoma: An Analysis of the National Cancer Data Base.
    Steuer CE; Behera M; Liu Y; Fu C; Gillespie TW; Saba NF; Shin DM; Pillai RN; Pakkala S; Owonikoko TK; Khuri FR; Ramalingam SS
    Clin Lung Cancer; 2017 May; 18(3):286-292. PubMed ID: 28043773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non-small cell lung cancer: A propensity-matched analysis.
    Brandt WS; Yan W; Zhou J; Tan KS; Montecalvo J; Park BJ; Adusumilli PS; Huang J; Bott MJ; Rusch VW; Molena D; Travis WD; Kris MG; Chaft JE; Jones DR
    J Thorac Cardiovasc Surg; 2019 Feb; 157(2):743-753.e3. PubMed ID: 30415902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additional chemotherapy improves survival in stage II-III pulmonary sarcomatoid carcinoma patients undergoing surgery: a propensity scoring matching analysis.
    Cen Y; Yang C; Ren J; Gong Y; Xie C
    Ann Transl Med; 2021 Jan; 9(1):24. PubMed ID: 33553317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Systemic Therapy in the Management of Stage I Large Cell Neuroendocrine Carcinoma of the Lung.
    Kujtan L; Muthukumar V; Kennedy KF; Davis JR; Masood A; Subramanian J
    J Thorac Oncol; 2018 May; 13(5):707-714. PubMed ID: 29391287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.